Publication: Minimal Residual Disease Response with Venetoclax Monotherapy in Relapsed/Refractory CLL Patients: VENICE I, Phase 3b Exploratory Analysis
Loading...
Date
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
…
Description
Keywords
Citation
WoS Q
Scopus Q
Source
Volume
61
Issue
Start Page
113
End Page
115